Immunocore Holdings plc (IMCR) Financials

IMCR Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 1.1 billion 699.6 million
March 31, 2026 1.1 billion 678.4 million
Dec. 31, 2025 1.1 billion 686.2 million
Sept. 30, 2025 1.1 billion 705.9 million

IMCR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -6.3 million 15.7 million
March 31, 2026 -15.5 million 6.3 million
Dec. 31, 2025 -35.5 million 8.3 million
Sept. 30, 2025 -5.2 million 9.8 million

IMCR Net Income

No data available :(

IMCR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 880.2 million 394.2 million 40.8 million
March 31, 2026 844.9 million 393.7 million 42.0 million
Dec. 31, 2025 864.2 million 393.1 million 43.6 million
Sept. 30, 2025 892.4 million 392.6 million 43.3 million

IMCR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 51.0 million
March 31, 2026 52.9 million
Dec. 31, 2025 50.3 million
Sept. 30, 2025 50.4 million

IMCR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 788982 73.9 million 43.9 million -
March 31, 2026 1.8 million 61.1 million 37.9 million -
Dec. 31, 2025 2.9 million 58.4 million 31.0 million -
Sept. 30, 2025 748000 70.6 million 39.8 million -

IMCR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 115.9 million 1.1 million
March 31, 2026 106.7 million 434000
Dec. 31, 2025 77.4 million 2.6 million
Sept. 30, 2025 103.7 million 513000

IMCR Revenue by Segment
Graph available only for paid members. Upgrade to see it.

IMCR

Price: $34.21

52 week price:
27.56
40.72

Earnings Per Share: -0.37 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United Kingdom

Volume: 522338

Market Capitalization: 1.8 billion

Links: